The SSC Platelet Immunology Register of VITT and VIITP: Towards standardization of laboratory and clinical parameters – DocWire News

This article was originally published here

J Thromb Haemost. 2021 Jun 2. doi: 10.1111/jth.15402. Online ahead of print.

ABSTRACT

A severe syndrome of thrombosis and thrombocytopenia has been described in patients vaccinated against severe acute respiratory distress syndrome coronavirus 2 (SARSCoV2) with a chimpanzee adenovirus vector encoding Spike protein (ChAdOx1 nCov-19, AstraZeneca).[1-6] as well as (Ad26.COV2.S, Johnson & Johnson/Janssen).[7] Currently, this novel immune thrombosis syndrome is known as vaccine-induced immune thrombotic thrombocytopenia (VITT) but has been described as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) and thrombotic thrombocytopenia syndrome (TTS) elsewhere.

PMID:34076338 | DOI:10.1111/jth.15402

More:
The SSC Platelet Immunology Register of VITT and VIITP: Towards standardization of laboratory and clinical parameters - DocWire News

Related Posts